Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi Q3 earnings beat market view
Sanofi Profit Growth Beats Market View on Early Start of Vaccine Sales
Sanofi is nearing a sale of a 50% stake in its consumer unit, valued at 16 billion euros in total, to boost clinical trials for next-generation drugs. CEO Paul Hudson's spending plans were initially met with a massive stock market slump a year ago but the shares have rebounded.
Sanofi Q3 earnings beat market view, boosted by vaccine sales
French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, helped by earlier-than-anticipated sales of seasonal vaccines.
Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales
The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, bringing in almost $700 million in the third quarter. Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3.
Sanofi posts Q3 revenue beat as Dupixent sales jump
Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in sales from its asthma therapy Dupixent.
37m
Sanofi expects FY24 business EPS growth of at least a LSD percentage at CER
On October 21, 2024, the 2024 business EPS guidance was upgraded to growth of at least a low single-digit percentage at CER supported by the ...
4d
on MSN
France takes stake in Sanofi as it moves ahead with CD&R deal
US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France. View on ...
4d
French government takes new blows over deal to sell painkiller maker to US fund
French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit Opella to a US ...
MedCity News
8d
Sanofi Puts Up €300M in New Targeted Radiation Cancer Therapy Pact With Orano
Sanofi
said the therapies developed by the
new
Orano Med entity will employ ... Orano Group, which is based in Paris and maintains U.S.
headquarters
in Bethesda, Maryland, provides products ...
Yen on MSN
3d
Sanofi's Opella sale faces political backlash amid fears of drug shortages
Paris: French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit ...
France 24 on MSN
10d
Painkiller sale plan to US gives France major headache
Political and trade union reactions came in hard and fast after the company announced last week that it was in talks with ...
theasialive
4d
French Government Warns U.S. Equity Firm Over Sanofi Deal: Penalties Await for Job and Production Relocation
In the French government issued a stern warning to Clayton, Dubilier & Rice (CD&R), an American private equity firm, ...
Yen on MSN
4d
Sanofi pursues sale of France's leading painkiller to US investment fund after controversy
French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...
4d
French Govt Takes New Blows Over Deal To Sell Painkiller Maker To US Fund
French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit to a US investment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback